pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3679 |
Genomic Coordinates | chr2: 134127125 - 134127192 |
Description | Homo sapiens miR-3679 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3679-5p | |||||||||||||||
Sequence | 6| UGAGGAUAUGGCAGGGAAGGGGA |28 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TOR1B | ||||||||||||||||||||
Synonyms | DQ1 | ||||||||||||||||||||
Description | torsin family 1 member B | ||||||||||||||||||||
Transcript | NM_014506 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TOR1B | |||||||||||||||||||||
3'UTR of TOR1B (miRNA target sites are highlighted) |
>TOR1B|NM_014506|3'UTR 1 GCTCCTATCCAGATGGGGTAGGAGACAGCTGGGAGGCTCCGCACGCCAGAGGCCTTGCCTTTCAGAAGAACCCTGAAGAC 81 CGCTTTGGGGTTTTGCCTGTTTGCACCTTAGACTTTTGGGTATAGAATCTTTTTTTTGAGAAGAGGTCTCACTCCGTCAT 161 CCAAGCTGGAGTGCAGTGGTGCAATCCTCAACTCACTGCAACCTCCGCTCCCGGTTTGAGTGATTCTCATGCCTCAGCCT 241 CCCGAGTAGCTGGGATTACAGGCATGAGCCACTGTGCCCAGCTGGGATATAGAATCTAAGAGTTGATTGTGGAAAACACG 321 TGAATCTATTGCGCGCATTTGTCATTTAGCAAGATGGCAGCAGTCCAGCTGTTCTTTGCAGCTGGAGATGAACTTTTAAA 401 AATCCCCTTCACACTTAATGTACTGACCGAGACAGAAGTACCTGAAAACAGCTGTGCATGGCAGGCCCGGCAATAGCTTC 481 TGACCCACAGCACCCGCGCCTCAGAAGCTACGGTCACAACTAAAGGAGTCCAGGGACTTGCTGCAGGCTGGGGGGCACTG 561 GGTGGTTCTCACCAGCAGGCTGCGGGGCACTGTGTTCTCATTGGCCAAAAACATCCTTTTGCTCTGTCTCGTTCTTTACA 641 CAGAGTTCACTGACTTGAAGTATACTCAGTTAAAATCGGGGCTGGAGGTGCAGACGGTGTCTGACCGGAGGATGTGGCCG 721 TGCCCGCCGAGCACTCTTGATCTGAGCTGACCTGTGTGTGTGTGTGGGGGGGGGTGGGGCCTTCACCTAAGACCTCTGCA 801 GCAGACCTGGACAGACAGGCCCCTCCCGCCTGTCCATCGCTCTAGCTGCTAATACAGCCCTGGCTGTGGAATCCTTCACC 881 GTCTCAGCTGGTATCAGCCCCAGCCTGCCTTGTGCCATATCTCAGCTTGGATCTCTGCTAGAGTCCCCCCAACCATATAT 961 CATAGAGTTGAATCACAATGAGACCGTTGGCTTTGAATTTGAGTCGTTGGTTCCCATGGTGAGATGCTTGTTAAGACTTT 1041 ATACTTGGGTCAATCTCTCACTTTATTTTGTAGAACCATTTGAAATCCTAGGATGTGCTTGTTCTGGAAGGATGACATGG 1121 GCCCAGACTGAACAAGTCAGCTTGATGATCTTAAATGATGGAAGTATAGGACGTTGCTTATTTTAAAACAAGGGAAGGAC 1201 ACAAAATGGAATGACTGCTTAGTCCTTTCTCAGATACTCTTAAAACAATTTTTTATTGTTAAATTTGTGGTAATACATGG 1281 TCACAACCGTGGATCAAACAAGGTCAGTCTAAAGTGGCAGGTCCTAGGTGTGACCTGATACCACCACCCTTTGTGGCAGC 1361 ACCGGGCTGGACTGCCCTGATCCCTGGGACGTGAGACTTAGCTTCCAGCCAGTGTGAATCATTGTATCTGTCTCATAATC 1441 ACAGCACAGCTGCAGACACAACAACGTGCAGCATTTTTTACATAAAAATATGGTAGAATTAATTTATGACATGGAAATGC 1521 CTTACGTGGTATCACACTTAGTCTTGAAAAAAACACCAAGGTGACGTTTAAAATTTTTAGTACATATCCTCAAATTGGAG 1601 CTAAGTTATACTTCTTTTATAACCTTTTGGGCATCTGGTCGAGAGAAGACAAGATTTTCTCTATTTACAGTGAGGCAATA 1681 AATATGTTTGCCACCTTTGGACTGCCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000259339.2 | 3UTR | CAAUCCUCAACUCACUGCAACCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
55 hsa-miR-3679-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT114494 | PNN | pinin, desmosome associated protein | 2 | 2 | ||||||||
MIRT169967 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | 2 | 6 | ||||||||
MIRT182181 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT189380 | TXLNA | taxilin alpha | 2 | 4 | ||||||||
MIRT364735 | TOR1B | torsin family 1 member B | 2 | 2 | ||||||||
MIRT445477 | KDM6A | lysine demethylase 6A | 2 | 2 | ||||||||
MIRT446333 | ATP5C1 | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 | 2 | 2 | ||||||||
MIRT446386 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 2 | 2 | ||||||||
MIRT446971 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT449793 | C1orf109 | chromosome 1 open reading frame 109 | 2 | 2 | ||||||||
MIRT451211 | PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 2 | 2 | ||||||||
MIRT452098 | NUCB2 | nucleobindin 2 | 2 | 2 | ||||||||
MIRT454036 | DDT | D-dopachrome tautomerase | 2 | 2 | ||||||||
MIRT461708 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT464957 | TWIST1 | twist family bHLH transcription factor 1 | 2 | 2 | ||||||||
MIRT465775 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT466925 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT471388 | PDPR | pyruvate dehydrogenase phosphatase regulatory subunit | 2 | 2 | ||||||||
MIRT473585 | MAT2A | methionine adenosyltransferase 2A | 2 | 2 | ||||||||
MIRT476070 | GRIN2A | glutamate ionotropic receptor NMDA type subunit 2A | 2 | 2 | ||||||||
MIRT477324 | EPHA2 | EPH receptor A2 | 2 | 2 | ||||||||
MIRT478244 | DDX3X | DEAD-box helicase 3, X-linked | 2 | 4 | ||||||||
MIRT480449 | C16orf72 | chromosome 16 open reading frame 72 | 2 | 6 | ||||||||
MIRT481866 | ANKRD50 | ankyrin repeat domain 50 | 2 | 2 | ||||||||
MIRT492032 | TSG101 | tumor susceptibility 101 | 2 | 4 | ||||||||
MIRT493737 | GRAP2 | GRB2-related adaptor protein 2 | 2 | 2 | ||||||||
MIRT495623 | PPP1R1C | protein phosphatase 1 regulatory inhibitor subunit 1C | 2 | 2 | ||||||||
MIRT497590 | SLC23A1 | solute carrier family 23 member 1 | 2 | 2 | ||||||||
MIRT504702 | ZNF117 | zinc finger protein 117 | 2 | 2 | ||||||||
MIRT507794 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT510653 | TMED7 | transmembrane p24 trafficking protein 7 | 2 | 4 | ||||||||
MIRT525534 | FSIP2 | fibrous sheath interacting protein 2 | 2 | 2 | ||||||||
MIRT531149 | CYGB | cytoglobin | 2 | 2 | ||||||||
MIRT536003 | MED13 | mediator complex subunit 13 | 2 | 2 | ||||||||
MIRT537056 | GPR180 | G protein-coupled receptor 180 | 2 | 2 | ||||||||
MIRT538297 | CSNK2A1 | casein kinase 2 alpha 1 | 2 | 2 | ||||||||
MIRT544755 | C8orf33 | chromosome 8 open reading frame 33 | 2 | 2 | ||||||||
MIRT544927 | MIS18BP1 | MIS18 binding protein 1 | 2 | 2 | ||||||||
MIRT556973 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT561714 | PPP2R2A | protein phosphatase 2 regulatory subunit Balpha | 2 | 2 | ||||||||
MIRT563632 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT564705 | ZNF322P1 | zinc finger protein 322 pseudogene 1 | 2 | 2 | ||||||||
MIRT572190 | CALU | calumenin | 2 | 2 | ||||||||
MIRT573900 | MKI67 | marker of proliferation Ki-67 | 2 | 2 | ||||||||
MIRT576073 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT576150 | Hmox1 | heme oxygenase 1 | 2 | 2 | ||||||||
MIRT614848 | PLEKHA6 | pleckstrin homology domain containing A6 | 2 | 4 | ||||||||
MIRT647592 | FAM109B | family with sequence similarity 109 member B | 2 | 2 | ||||||||
MIRT657009 | KCNMB4 | potassium calcium-activated channel subfamily M regulatory beta subunit 4 | 2 | 2 | ||||||||
MIRT691268 | GET4 | golgi to ER traffic protein 4 | 2 | 2 | ||||||||
MIRT695778 | DENR | density regulated re-initiation and release factor | 2 | 2 | ||||||||
MIRT698089 | TPM1 | tropomyosin 1 | 2 | 2 | ||||||||
MIRT732571 | IGLL5 | immunoglobulin lambda like polypeptide 5 | 1 | 0 | ||||||||
MIRT733722 | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase | 3 | 0 | ||||||||
MIRT734354 | GREM1 | gremlin 1, DAN family BMP antagonist | 1 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|